Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer

OBJECTIVES: In lung cancer, surgery remains the most curative treatment and limited resection is beneficial for patients with low cardiopulmonary function and low malignancy tumors. However, there are no biomarkers of low malignancy to select candidates for limited resection without compromising the...

Descripción completa

Detalles Bibliográficos
Autores principales: Morimoto, Hirofumi, Hida, Yasuhiro, Maishi, Nako, Nishihara, Hiroshi, Hatanaka, Yutaka, Li, Cong, Matsuno, Yoshihiro, Nakamura, Toru, Hirano, Satoshi, Hida, Kyoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088962/
https://www.ncbi.nlm.nih.gov/pubmed/33709550
http://dx.doi.org/10.1111/1759-7714.13907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088962/
https://www.ncbi.nlm.nih.gov/pubmed/33709550
http://dx.doi.org/10.1111/1759-7714.13907

Ejemplares similares